Croatian guidelines for specific preventive treatment of migraine with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) (eptinezumab, fremanezumab, and galcanezumab) or the CGRP receptor (erenumab)

Calcitonin gene-related peptide (CGRP) plays a key role in the pathophysiology of migraine, acting on CGRP receptors in the trigeminovascular system, causing neurogenic inflammation and vasodilation, and promoting nociception. Four specific monoclonal antibodies targeting CGRP are available for p...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Davor Jančuljak, Damir Petravić, Darija Mahović Lakušić, Arijana Lovrenčić-Huzjan, Koraljka Bačić Baronica, Marijana Bosnar Puretić, Zlatko Hucika, Marina Titlić, Zvonimir Popović, Zoran Tomić, Maristela Stojić, Vanja Bašić Kes
Format:	Artigo
Sprog:	Inglês
Udgivet:	Sestre Milosrdnice University hospital, Institute of Clinical Medical Research 2024-01-01
Serier:	Acta Clinica Croatica
Fag:	Migraine - Prevention,Treatment Calcitonin gene-related peptide (CGRP) Monoclonal antibody Guidelines Eptinezumab, Fremanezumab, Galcanezumab, Erenumab
Online adgang:	https://hrcak.srce.hr/file/474344
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!